Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Filings indexed 854 across all filing types
Latest filing 2017-11-27 Report Publication Anno…
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
aap Implantate AG to present at German Equity Forum 2017
Report Publication Announcement Classification · 99% confidence The document is a short corporate news release announcing that aap Implantate AG will present at the German Equity Forum 2017. It explicitly states that the accompanying presentation materials will be made available on the corporate website later. Because the document is short (4617 characters) and its primary function is to announce the future availability of presentation materials rather than being the presentation itself, it fits the definition of a Report Publication Announcement (RPA). It is not the presentation (IP) or a general regulatory filing (RNS), but specifically an announcement about the publication of materials.
2017-11-27 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of the person (Biense Visser), their position (Member of the administrative or supervisory body), the nature of the transaction ('Acquisition'), the financial instrument (Share), and the price/volume details. This content directly matches the definition for Director's Dealing.
2017-11-21 English
aap Implantate AG: Double-digit trauma sales growth in Q3 and 9M/2017
Earnings Release Classification · 100% confidence The document is titled 'aap Implantate AG: Double-digit trauma sales growth in Q3 and 9M/2017' and explicitly mentions 'Quarter Results/Quarterly / Interim Statement' in the DGAP header. It provides detailed financial figures (Sales, EBITDA, Gross margin) for the third quarter (Q3/2017) and the first nine months (9M/2017) of the financial year, along with an outlook for FY/2017. This content structure—detailed financial performance for a period shorter than a full year—is characteristic of an Interim Report, which corresponds to the 'Interim / Quarterly Report' definition. 9M 2017
2017-11-14 English
Quartalsfinanzbericht
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quartalsmitteilung' (Quarterly Statement) for the 3rd quarter of 2017 for aap Implantate AG. It contains detailed financial tables (Umsatz, EBITDA, EBIT, Cash-Flow, etc.), a management discussion (Vorwort des Vorstands), and analysis of business performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-14 German
Q3 statement / Q3 financial report 2017
Interim / Quarterly Report Classification · 100% confidence The document is a '3rd quarter 2017 Quarterly Statement' for aap Implantate AG. It contains detailed financial tables (unaudited), a business review, management board foreword, and analysis of earnings and asset positions. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report (RPA) as it contains the actual financial data and analysis. 9M 2017
2017-11-14 English
Q3 Mitteilung / Q3 Finanzbericht 2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quartalsmitteilung' (Quarterly Statement) for the third quarter of 2017 for 'aap Implantate AG'. It contains detailed financial tables (balance sheet, income statement, cash flow), management commentary, and analysis of business performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-14 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.